Circulation Research, Vol 67, 501-509, Copyright © 1990 by American Heart Association

ARTICLES

Potentiation of reperfusion-associated ventricular fibrillation by left ventricular hypertrophy

AL Taylor, R Winter, F Thandroyen, S Murphree, LM Buja, R Eckels, P Pastor and M Kremers
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.

Important electrophysiological alterations that may predispose hearts to arrhythmias have been described for hypertrophied myocytes, and hypertrophy coupled with ischemia has been associated with an increased incidence of sudden death; however, an influence of hypertrophy on reperfusion arrhythmias has not been previously described. We hypothesized that reperfusion-associated arrhythmias would be potentiated by left ventricular hypertrophy. After induction of renovascular hypertension, 37 awake, unsedated dogs (17 with left ventricular hypertrophy and 20 without hypertrophy) underwent 15 minutes of coronary artery occlusion and reperfusion. All dogs were pretreated with lidocaine bolus injections and with lidocaine by continuous infusion during coronary occlusion and reperfusion. Reperfusion-associated ventricular fibrillation occurred in seven of 17 dogs with left ventricular hypertrophy versus one of 18 dogs without hypertrophy (p less than or equal to 0.05). The presence of hypertension was not significantly associated with an increased incidence of reflow ventricular arrhythmias. Neither QT interval nor area-at-risk was different between the dogs with and without reperfusion ventricular fibrillation; however, increased heart rate just before reperfusion did correlate with an increased incidence of ventricular fibrillation at reperfusion. Thus, 1) left ventricular hypertrophy was associated with a significantly increased incidence of reperfusion-induced ventricular fibrillation after 15 minutes of ischemia, 2) this increased incidence was independent of the presence of hypertension, and 3) lidocaine protected control and hypertrophied hearts against ventricular fibrillation during ischemia but was ineffective in protecting hypertrophied hearts against reperfusion- induced ventricular fibrillation.

This article has been cited by other articles:

				A. Rubulis, J. Jensen, G. Lundahl, J. Tapanainen, and L. Bergfeldt Ischemia induces aggravation of baseline repolarization abnormalities in left ventricular hypertrophy: a deleterious interaction J Appl Physiol, July 1, 2006; 101(1): 102 - 110. [Abstract] [Full Text] [PDF]

				M. Galinanes and A. G Fowler Role of clinical pathologies in myocardial injury following ischaemia and reperfusion Cardiovasc Res, February 15, 2004; 61(3): 512 - 521. [Abstract] [Full Text] [PDF]

				B. Swynghedauw, B. Chevalier, D. Charlemagne, P. Mansier, and F. Carre Cardiac hypertrophy, arrhythmogenicity and the new myocardial phenotype. II. The cellular adaptational process Cardiovasc Res, July 1, 1997; 35(1): 6 - 12. [Abstract] [Full Text] [PDF]

				S. J. Rials, Y. Wu, N. Ford, F. J. Pauletto, S. V. Abramson, A. M. Rubin, R. A. Marinchak, and P. R. Kowey Effect of Left Ventricular Hypertrophy and Its Regression on Ventricular Electrophysiology and Vulnerability to Inducible Arrhythmia in the Feline Heart Circulation, January 15, 1995; 91(2): 426 - 430. [Abstract] [Full Text]